Ivers-Read Sells 3000 Shares of Clovis Oncology, Inc. (CLVS) Stock

Dow Chemical Company (The) now has $80.14 billion valuation. In terms of the mechanics underlying that movement, traders will want to note that the stock is trading on a float of 16.02% with $46.61 Million sitting short, betting on future declines.

The counter witnessed a trading volume of 1.6 million shares versus an average volume of 1.88 million shares during last trading session. It has outperformed by 35.54% the S&P500. (NASDAQ:CLVS). The stock has a current ATR of 4.41. Meeder Asset Management Inc now controls 309 shares with a value of $29,000. About 325 shares traded. Clovis Oncology Inc (NASDAQ:CLVS) has risen 282.71% since July 18, 2016 and is uptrending. It has outperformed by 266.01% the S&P500.

On June 20, 2017 the stock rating was set at "Buy" by Janney Capital a boost from the previous "Neutral" rating. The Dow Chemical Company had 42 analyst reports since August 20, 2015 according to SRatingsIntel. RBC Capital Markets has "Buy" rating and $7600 target. (CLVS) Worth a Look: "Stock Jumps 6.3% June 22, 2017" published on June 22, 2017, published: "What To Expect From Clovis Oncology Following Rubraca Approval" on June 23, 2017. The firm has "Buy" rating given on Monday, June 19 by Jefferies. Oppenheimer Holdings, Inc. began coverage on Clovis Oncology in a research report on Friday, June 23rd. The firm has "Outperform" rating by Credit Suisse given on Wednesday, September 21. The firm has "Buy" rating by UBS given on Monday, October 10.

The company's consensus rating on Reuter's scale slipped from 2.17 to 2 during a month.

Analysts await Proofpoint Inc (NASDAQ:PFPT) to report earnings on July, 27 after the close. (CLVS) has made a move of -3.29% over the past month, which has come on weak relative transaction volume. WR's profit would be $79.43 million giving it 22.03 P/E if the $0.56 EPS is correct. The biopharmaceutical company reported ($1.33) earnings per share for the quarter, topping the consensus estimate of ($1.43) by $0.10.

Investors sentiment increased to 1.52 in Q4 2016. 128 funds opened positions while 459 raised stakes. 790.77 million shares or 7.17% more from 737.86 million shares in 2016Q3 were reported. America First Investment Advsr Limited Com owns 287 shares or 0.01% of their United States portfolio. Deutsche Financial Bank Ag holds 126,195 shares or 0% of its portfolio. More interesting news about Clovis Oncology Inc (NASDAQ:CLVS) were released by: and their article: "Here's Why Clovis Oncology Inc". Td Asset Management stated it has 17,226 shares. Nelson Van Denburg & Campbell Wealth Mngmt Ltd Co holds 100 shares. Lynch In holds 1.57% or 65,035 shares in its portfolio. Numeric Invsts Ltd reported 12,700 shares. Moreover, Horrell Capital Management Inc. has 0.39% invested in the company for 27,160 shares. Creative Planning owns 8,674 shares. Nevro Corp was raised too.

Investors sentiment decreased to 1.03 in 2016 Q4. Its up 0.15, from 0.94 in 2016Q3.

Large investors have recently modified their holdings of the company.

These funds have also shifted positions in (CLVS). Polar Capital Llp invested in 478,427 shares or 0.54% of the stock.

Clovis Oncology (NASDAQ:CLVS) traded down 1.34% during mid-day trading on Tuesday, reaching $83.85. Bank of Montreal Can raised its stake in Clovis Oncology by 284.9% in the second quarter. Wasatch Advsr accumulated 0.38% or 355,300 shares. Voloridge Invest Mngmt Lc reported 183,693 shares. South Texas Money Management Ltd, Texas-based fund reported 2.36M shares. Dekabank Deutsche Girozentrale owns 500 shares. Columbia Wanger Asset Management Lc invested 0.12% in Clovis Oncology Inc (NASDAQ:CLVS).

Meag Munich Ergo Kapitalanlagegesellschaft Mbh holds 1.37% of its portfolio in HP Inc for 1.26 million shares. Invesco reported 114,298 shares. Stifel Nicolaus upped their price objective on shares of Clovis Oncology from $86.00 to $125.00 and gave the company a buy rating in a research note on Monday, June 19th. Therefore 76% are positive. The SI to Clovis Oncology Incorporated's float is 28.56%. As per Tuesday, September 1, the company rating was downgraded by Zacks.

Clovis Oncology, Inc. has a 12-month low of $13.43 and a 12-month high of $96.92. On Tuesday, August 11 the stock rating was maintained by Deutsche Bank with "Buy".

Clovis Oncology (NASDAQ:CLVS) last posted its earnings results on Wednesday, May 3rd. SunTrust has "Buy" rating and $30 target. As per Monday, January 23, the company rating was maintained by Stifel Nicolaus. The firm has "Overweight" rating given on Thursday, January 26 by PiperJaffray.

J P Morgan Chase & Co reiterated their overweight rating on shares of Clovis Oncology, Inc. As per Friday, September 23, the company rating was maintained by Suntrust Robinson. The stock has "Sell" rating by Chardan Capital Markets on Friday, February 3.

Since March 15, 2017, it had 0 insider buys, and 3 insider sales for $528,600 activity. 3,000 Clovis Oncology Inc (NASDAQ:CLVS) shares with value of $200,970 were sold by IVERS-READ GILLIAN C. Equities research analysts expect that Clovis Oncology will post ($5.66) earnings per share for the current fiscal year. Next quarter's EPS is estimated at $-1.21 with next year's EPS projected to be $-2.01.

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Like this



20 July 2017
The Albemarle Corporation (ALB) Shares Sold by Grimes & Company Inc
Marietta Investment Partners LLC bought a new stake in Albemarle Corporation during the first quarter worth about $2,574,000. The Company operates through three segments: Lithium and Advanced Materials, Bromine Specialties and Refining Solutions.

20 July 2017
LPL Financial Holdings Inc
On average, analysts expect that LPL Financial Holdings Inc. will post $2.47 earnings per share for the current year. Raymond James Trust Na holds 0.04% of its portfolio in LPL Financial Holdings Inc (NASDAQ:LPLA) for 13,436 shares.

20 July 2017
Tough day for TT at Commonwealth Youth Games
This media house does not correct any spelling or grammatical error within press releases and commentaries. IT was a tough start for Trinidad and Tobago at the Commonwealth Youth Games in Bahamas, yesterday .

20 July 2017
Sippican Capital Advisors Has $463000 Stake in Enbridge Energy, LP (EEP)
BidaskClub lowered Enbridge Energy, L.P. from a "sell" rating to a "strong sell" rating in a research note on Saturday, June 10th. The pipeline company reported $0.16 EPS for the quarter, topping the Thomson Reuters' consensus estimate of $0.07 by $0.09.

20 July 2017
Amazon wants to help you cook at home with meal kits
As of reporting the news, Amazon's stock continues to rise and Blue Apron's is seeing a notable drop off. Blue Apron CEO Matt Salzberg has remained confident in his company's future during public interviews.

20 July 2017
$32 Million in Ethereum Stolen From Several Multisignature Addresses
The Ether stolen from Parity multi-sig accounts was transferred into this Ethereum wallet , now holding 153,017.021336727 Ether. Parity wallet is an Ethereum client that can be integrated directly into a web browser and only those wallets were affected.

20 July 2017
Earnings Clues on Fitbit, Inc. (FIT), Huntington Bancshares Incorporated (HBAN) Analyst's Predictions
Finally, Affinity Wealth Management purchased a new stake in Huntington Bancshares during the first quarter worth about $141,000. Following the purchase, the executive vice president now owns 35,543 shares in the company, valued at approximately $459,215.56.

20 July 2017
Enbridge Energy, LP (EEP) Getting Somewhat Positive Media Coverage, Accern Reports
Anchor Advisors Ltd Liability Co accumulated 745,767 shares. 87,657 are owned by Asset Ltd Company. 2,500 are owned by Strs Ohio. Their average price target spell out an upbeat performance - a 14% and would give EEP a market capitalization of almost $6.38B.

20 July 2017
South32 Ltd. (OTC:SOUHY) Lowered to Hold at HSBC Holdings plc
They now have a "buy" rating on the stock. 5/10/2017 - South32 had its "sell" rating reaffirmed by analysts at Liberum Capital. The company has a 50-day moving average price of $9.94 and a 200 day moving average price of $10.19.

20 July 2017
Red Sox Win Behind Pomeranz's Strong Outing
He tossed 6 2/3 innings, allowing one unearned run on three hits while striking out three and issuing five walks. Pedroia's error led to Jose Bautista's sacrifice fly that got the Blue Jays on the board in the fifth.